Ignite Creation Date:
2024-05-06 @ 3:07 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04529772
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-27
First Post:
2020-08-25
Brief Title:
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL ACE-LY-312
Sponsor:
Acerta Pharma BV
Organization:
Acerta Pharma BV
Organization Data
Organization:
Acerta Pharma BV
Class:
INDUSTRY
Study ID:
D8227C00001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Acerta Pharma BV
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |